A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. (Q45251395)
scientific article published on 3 February 2005
Language:
(P31) (Q13442814)
(P50) (Q38319488)
(Q909289)
(Q51974002)
(Q63808874)
(P304) 4484-4491
(P407) (Q1860)
(P433) 11
(P478) 105
(P577) Thursday, February 3, 2005
(P921) (Q11829285)
(P1433) (Q885070)
(P1476) "A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival" (language: en)
(P2093) Azra J Alvi
Belinda Austen
Victoria J Weston
Christopher Fegan
David MacCallum
Athos Gianella-Borradori
Judith E Powell
A Malcolm R Taylor
Paul A H Moss
other details
description scientific article published on 3 February 2005

External Links